１企业规模小而散，必须走规模化、集约化道路我国现有制药生产企业７０００多家，绝大多数企业规模小，企业间产品雷同严重，所有制结构单一，多数为国有或集体企业，生产条件落后，技术力量薄弱，资产负债率高，在国际经济中缺乏竞争力。有分析预测，在２１世纪，全球前７０ 1 small and scattered enterprises, we must take the large-scale, intensive way China’s existing pharmaceutical manufacturing more than 7,000, the vast majority of small-scale enterprises, similar serious between products, ownership structure of a single, most of the state-owned or collective enterprises, production Conditions are backward, technology is weak, assets and liabilities are high, and they are not competitive in the international economy. Some analysts predict that in the 21st century, the world’s top 70